{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:32:31Z","timestamp":1792690351513,"version":"4.5.0"},"posted":{"date-parts":[[2026,2,18]]},"group-title":"Neurology","reference-count":68,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Subtle alterations in awareness may emerge in the preclinical stage of Alzheimer\u2019s disease (AD), yet their clinical significance and translational relevance remain unclear. This study aimed to evaluate associations of distinct awareness trajectories with clinical and multimodal AD biomarker measurements in cognitively unimpaired (CU) older adults.<\/jats:p>\n                <jats:p>\n                  This prospective study analyzed data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer\u2019s (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) cohorts (\u223c4.5-year follow-up). Awareness trajectories were defined using a mixed-effects regression model estimating normative longitudinal changes in the Cognitive Function Index (Participant\u2014Study Partner Discrepancy). Based on individual-specific time slopes, participants were classified into three trajectories: stable awareness, heightened awareness (hypernosognosia), and decreased awareness (anosognosia). Study outcomes included the Preclinical Alzheimer\u2019s Cognitive Composite (PACC), Alzheimer\u2019s Disease Cooperative Study (ADCS) Activities of Daily Living Prevention Instrument (ADL-PI), Clinical Dementia Rating (CDR), plasma phosphorylated-tau at threonine 217 (p-tau217), A\u03b2-PET ([\n                  <jats:sup>18<\/jats:sup>\n                  F]-florbetapir), tau-PET ([\n                  <jats:sup>18<\/jats:sup>\n                  F]-flortaucipir), and gray matter volume (GMv) via structural magnetic resonance imaging. The associations of awareness trajectories with clinical and multimodal biomarker measurements were evaluated using the general linear model framework, primarily implemented as mixed-effects, including voxel-wise and Braak-stage regional approaches for neuroimaging data. Sequential\u2014longitudinal multimodal neuroimaging mediation analyses evaluated whether regional tau-PET propagation contributed to the emergence of distinct awareness trajectories through downstream GMv loss.\n                <\/jats:p>\n                <jats:p>In the full sample (n= 1,643) the mean age was 71.49[\u00b14.72] years, \u223c60% female sex, mean education of 16.63[\u00b12.74] years, \u223c69% A\u03b2-PET positive, and \u223c27% showing clinical progression on CDR-Global (&gt;0). Compared to stable awareness trajectory (n= 1,325[\u223c80%]; \u223c67% A\u03b2-PET positive; \u223c18% clinical progression), hypernosognosia trajectory (n= 157[\u223c10%]; \u223c68% A\u03b2-PET positive; \u223c36% clinical progression) showed modest clinical implications and limited biomarker associations, including plasma p-tau217, medial temporal tau-PET, and brain structure. In contrast, anosognosia trajectory (n= 161[\u223c10%]; \u223c89% A\u03b2-PET positive; \u223c90% clinical progression) was associated with more adverse outcomes, including steeper cognitive and functional decline, higher risk of progression, greater plasma p-tau217, neocortical tau-PET, and widespread neurodegeneration. Associations between regional tau-PET and awareness trajectories were partially mediated by GMv loss, with sequential Braak-stage II tau-PET effects in hypernosognosia and generalized tau-PET propagation effects extending across Braak-stages II-IV in anosognosia.<\/jats:p>\n                <jats:p>These findings suggest that distinct awareness trajectories emerge from stage-specific pathological processes, alongside downstream neurodegenerative mechanisms, reflecting separate clinical consequences. This study identifies anosognosia as a high-risk trajectory across the early stages of the AD continuum, while suggesting that hypernosognosia may reflect both age-related and early AD-related processes.<\/jats:p>","DOI":"10.64898\/2026.02.16.26346402","type":"posted-content","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:10:36Z","timestamp":1771463436000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical and Pathological Progression of Awareness Trajectories in Preclinical Alzheimer\u2019s Disease"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1150-2619","authenticated-orcid":false,"given":"David","family":"L\u00f3pez-Martos","sequence":"first","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital & Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Barcelona\u03b2eta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"Hospital del Mar Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-800X","authenticated-orcid":false,"given":"Gonzalo","family":"S\u00e1nchez-Benavides","sequence":"additional","affiliation":[{"name":"Barcelona\u03b2eta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"Hospital del Mar Research Institute, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4730-5341","authenticated-orcid":false,"given":"Oriol","family":"Grau-Rivera","sequence":"additional","affiliation":[{"name":"Barcelona\u03b2eta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain"},{"name":"Hospital del Mar Research Institute, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain"},{"name":"Servei de Neurologia, Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5878-8930","authenticated-orcid":false,"given":"Rebecca","family":"Amariglio","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital & Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5708-4925","authenticated-orcid":false,"given":"Mark","family":"Dubbelman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital & Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3892-9742","authenticated-orcid":false,"given":"Jennifer","family":"Gatchel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"McLean Hospital, Harvard Medical School, Belmont, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-2355","authenticated-orcid":false,"given":"Gad A.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital & Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-0178","authenticated-orcid":false,"given":"Ibai","family":"Diez","sequence":"additional","affiliation":[{"name":"Center for Inflammation Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA"},{"name":"Computational Neuroimaging Lab, Biobizkaia Health Research Institute, Barakaldo, Spain"},{"name":"IKERBASQUE Basque Foundation for Science, Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9425-1059","authenticated-orcid":false,"given":"Patrizia","family":"Vannini","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital & Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the A4 Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026022011451993000_2026.02.16.26346402v1.1","doi-asserted-by":"publisher","DOI":"10.1080\/01688639008400962"},{"key":"2026022011451993000_2026.02.16.26346402v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-498045-7.50014-1"},{"key":"2026022011451993000_2026.02.16.26346402v1.3","doi-asserted-by":"publisher","DOI":"10.1080\/01688638908400882"},{"key":"2026022011451993000_2026.02.16.26346402v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-021-01155-6"},{"key":"2026022011451993000_2026.02.16.26346402v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.085373"},{"key":"2026022011451993000_2026.02.16.26346402v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cortex.2014.07.019"},{"key":"2026022011451993000_2026.02.16.26346402v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-9452(08)70697-X"},{"key":"2026022011451993000_2026.02.16.26346402v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-9452(08)70696-8"},{"key":"2026022011451993000_2026.02.16.26346402v1.9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25649"},{"issue":"11","key":"2026022011451993000_2026.02.16.26346402v1.10","first-page":"e932","article-title":"Anosognosia predicts default mode network hypometabolism and clinical progression to dementia","volume":"90","year":"2018","journal-title":"Neurology"},{"key":"2026022011451993000_2026.02.16.26346402v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2017.05.020"},{"key":"2026022011451993000_2026.02.16.26346402v1.12","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24462"},{"key":"2026022011451993000_2026.02.16.26346402v1.13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnbeh.2018.00100","article-title":"Neural correlates of anosognosia in Alzheimer\u2019s disease and mild cognitive impairment: a multi-method assessment","volume":"12","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"2026022011451993000_2026.02.16.26346402v1.14","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-201246"},{"key":"2026022011451993000_2026.02.16.26346402v1.15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cortex.2014.10.010","article-title":"Neuroanatomical correlates of awareness of illness in patients with amnestic mild cognitive impairment who will or will not convert to Alzheimer\u2019s disease","volume":"61","year":"2014","journal-title":"Cortex"},{"key":"2026022011451993000_2026.02.16.26346402v1.16","doi-asserted-by":"crossref","first-page":"631518","DOI":"10.3389\/fpsyt.2021.631518","article-title":"Anosognosia in mild cognitive impairment: lack of awareness of memory difficulties characterizes prodromal Alzheimer\u2019s disease","volume":"12","year":"2021","journal-title":"Front Psychiatry"},{"key":"2026022011451993000_2026.02.16.26346402v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00497-9"},{"key":"2026022011451993000_2026.02.16.26346402v1.18","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1415994"},{"key":"2026022011451993000_2026.02.16.26346402v1.19","doi-asserted-by":"publisher","DOI":"10.1002\/gps.3972"},{"key":"2026022011451993000_2026.02.16.26346402v1.20","doi-asserted-by":"crossref","first-page":"1335878","DOI":"10.3389\/fnagi.2024.1335878","article-title":"Anosognosia is associated with increased prevalence and faster development of neuropsychiatric symptoms in mild cognitive impairment","volume":"16","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"2026022011451993000_2026.02.16.26346402v1.21","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617713001276"},{"key":"2026022011451993000_2026.02.16.26346402v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cortex.2012.09.006"},{"key":"2026022011451993000_2026.02.16.26346402v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.concog.2009.07.005"},{"key":"2026022011451993000_2026.02.16.26346402v1.24","first-page":"456","article-title":"Anosognosia and metacognition in Alzheimer\u2019s disease: Insights from experimental psychology","volume":"1","year":"2016","journal-title":"The Oxford handbook of metamemory"},{"key":"2026022011451993000_2026.02.16.26346402v1.25","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0734-1"},{"key":"2026022011451993000_2026.02.16.26346402v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-07076-7"},{"key":"2026022011451993000_2026.02.16.26346402v1.27","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12203"},{"key":"2026022011451993000_2026.02.16.26346402v1.28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001935"},{"key":"2026022011451993000_2026.02.16.26346402v1.29","doi-asserted-by":"crossref","first-page":"802501","DOI":"10.3389\/fnagi.2021.802501","article-title":"Episodic memory impairment mediates the loss of awareness in mild cognitive impairment","volume":"13","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"2026022011451993000_2026.02.16.26346402v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr020"},{"key":"2026022011451993000_2026.02.16.26346402v1.31","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.697234"},{"key":"2026022011451993000_2026.02.16.26346402v1.32","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13905"},{"key":"2026022011451993000_2026.02.16.26346402v1.33","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1394460"},{"key":"2026022011451993000_2026.02.16.26346402v1.34","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00007"},{"key":"2026022011451993000_2026.02.16.26346402v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2017.04.002"},{"key":"2026022011451993000_2026.02.16.26346402v1.36","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00626-1"},{"key":"2026022011451993000_2026.02.16.26346402v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30368-0"},{"key":"2026022011451993000_2026.02.16.26346402v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.01.001"},{"key":"2026022011451993000_2026.02.16.26346402v1.39","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170399"},{"key":"2026022011451993000_2026.02.16.26346402v1.40","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180378"},{"key":"2026022011451993000_2026.02.16.26346402v1.41","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00700-8"},{"key":"2026022011451993000_2026.02.16.26346402v1.42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007941"},{"key":"2026022011451993000_2026.02.16.26346402v1.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2305032"},{"key":"2026022011451993000_2026.02.16.26346402v1.44","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.0387"},{"key":"2026022011451993000_2026.02.16.26346402v1.45","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.3375"},{"key":"2026022011451993000_2026.02.16.26346402v1.46","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.803"},{"key":"2026022011451993000_2026.02.16.26346402v1.47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.6669"},{"key":"2026022011451993000_2026.02.16.26346402v1.48","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617708080302"},{"key":"2026022011451993000_2026.02.16.26346402v1.49","unstructured":"Wechsler D. Wechsler memory scale-revised. Psychological Corporation. Published online 1987."},{"key":"2026022011451993000_2026.02.16.26346402v1.50","unstructured":"Wechsler D . Wechsler Adult Intelligence Scale-Revised (WAIS-R). Psychological Corporation; 1981."},{"key":"2026022011451993000_2026.02.16.26346402v1.51","doi-asserted-by":"crossref","unstructured":"Folstein MF , Folstein SE , Mchugh PR. \u201cMini-Mental State\u201d: A Practical Method for Grading the Cognitive State of Patients for the Clinician. Vol 12. Pergamon Press; 1975.","DOI":"10.1037\/t07757-000"},{"key":"2026022011451993000_2026.02.16.26346402v1.52","doi-asserted-by":"publisher","DOI":"10.1097\/01.wad.0000213873.25053.2b"},{"key":"2026022011451993000_2026.02.16.26346402v1.53","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2412-a"},{"key":"2026022011451993000_2026.02.16.26346402v1.54","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2024.134"},{"key":"2026022011451993000_2026.02.16.26346402v1.55","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2024.122"},{"key":"2026022011451993000_2026.02.16.26346402v1.56","doi-asserted-by":"publisher","DOI":"10.1037\/neu0000208"},{"key":"2026022011451993000_2026.02.16.26346402v1.57","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-025-00835-z"},{"key":"2026022011451993000_2026.02.16.26346402v1.58","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-022-00204-0"},{"key":"2026022011451993000_2026.02.16.26346402v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/S41582-024-00942-2"},{"key":"2026022011451993000_2026.02.16.26346402v1.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2022.06.007"},{"issue":"12","key":"2026022011451993000_2026.02.16.26346402v1.61","doi-asserted-by":"crossref","first-page":"e2027472","DOI":"10.1001\/jamanetworkopen.2020.27472","article-title":"Trajectory of unawareness of memory decline in individuals with autosomal dominant Alzheimer disease","volume":"3","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026022011451993000_2026.02.16.26346402v1.62","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2024.125"},{"key":"2026022011451993000_2026.02.16.26346402v1.63","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afn147"},{"key":"2026022011451993000_2026.02.16.26346402v1.64","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac041"},{"key":"2026022011451993000_2026.02.16.26346402v1.65","doi-asserted-by":"publisher","DOI":"10.1017\/S135561771400068X"},{"key":"2026022011451993000_2026.02.16.26346402v1.66","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150986"},{"issue":"8","key":"2026022011451993000_2026.02.16.26346402v1.67","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1017\/S1355617718000486","article-title":"Increasing inaccuracy of self-reported subjective cognitive complaints over 24 months in empirically derived subtypes of mild cognitive impairment","volume":"24","year":"2018","journal-title":"Journal of the International Neuropsychological Society"},{"key":"2026022011451993000_2026.02.16.26346402v1.68","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9964"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.02.16.26346402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:45:32Z","timestamp":1771616732000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.02.16.26346402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":68,"URL":"https:\/\/doi.org\/10.64898\/2026.02.16.26346402","relation":{},"subject":[],"published":{"date-parts":[[2026,2,18]]},"subtype":"preprint"}}